L

Lys Therapeutics

9 employees

Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Stroke
Antibody
Neurovascular diseases
Parkinson's Disease
Drug development
Parkinson
Neurodegenerative disorders
Multiple Sclerosis
Neurology
Health Care
Pharma
Healthcare
Medical
Life Science

Date founded

2021

Funding rounds raised

Total raised

$3.1M

from 1 investors over 1 rounds

L

Lys Therapeutics raised $3.1M on November 14, 2022

Investors: HTH - Health Technologies Holding

FAQ